Log In
person
Biocon Ltd
summarize
4 total product lines
calendar_month
Revenue as of 12/31/2020
| Reporting Segmentarrow_drop_up | Product Line | Amount (INR) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (INR) | Percentage |
| Biologics |
Biosimilars; sold through distributor
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
18B | 28.27% |
| Branded Formulations |
Brand-Name Generic Pharmaceuticals
These companies manufacture generic drugs with a brand name.
|
5.36B | 8.42% |
| Research Services |
Contract Research for Drug Manufacturers
These companies do contract services for biotech and pharmaceutical companies.
|
19.37B | 30.42% |
| Small Molecules |
Active Pharma Ingredients
These companies develop and manufacture Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs.
|
20.94B | 32.88% |
| keyboard_arrow_down |
Biologics
Biosimilars; sold through distributor
|
18B | 28.27% |
| keyboard_arrow_right |
These companies research, develop, and manufacture biosimilars, or biopharmaceutical products that are marketed as an alternative to other companies' products.
|
||
| keyboard_arrow_down |
Branded Formulations
Brand-Name Generic Pharmaceuticals
|
5.36B | 8.42% |
| keyboard_arrow_right |
These companies manufacture generic drugs with a brand name.
|
||
| keyboard_arrow_down |
Research Services
Contract Research for Drug Manufacturers
|
19.37B | 30.42% |
| keyboard_arrow_right |
These companies do contract services for biotech and pharmaceutical companies.
|
||
| keyboard_arrow_down |
Small Molecules
Active Pharma Ingredients
|
20.94B | 32.88% |
| keyboard_arrow_right |
These companies develop and manufacture Active Pharmaceutical Ingredients (APIs) that are used to create finished drugs.
|
||